Primary Prevention Aspirin Eligibility Under a Contemporary Risk Framework
This cross-sectional study estimates eligibility for low-dose aspirin for primary prevention based on updated Predicting Risk of Cardiovascular Disease Events risk thresholds.
Authors
- Michael G. Nanna (ORCID: https://orcid.org/0000-0001-5745-1636)
- Sridhar Mangalesh (ORCID: https://orcid.org/0000-0002-2645-3994)
- Abdulla A. Damluji (ORCID: https://orcid.org/0000-0002-8774-6416)
- Sharanya Kaushik (ORCID: https://orcid.org/0000-0002-3310-4792)
- Raiza Rossi (ORCID: https://orcid.org/0000-0001-6898-2192)
- Shefa Arya Nezhad (ORCID: https://orcid.org/0000-0002-0935-1806)
- Armin Nouri
Institutions
- Albert Einstein College of Medicine (US)
- Cleveland Clinic (US)
- Jacobi Medical Center (US)
- Yale University (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1001/jamanetworkopen.2026.46419
- Primary Topic
- Antiplatelet Therapy and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00